PURPOSE: We compared the prevalence, level of bother and effect on daily activities of urinary incontinence among women with type 1 diabetes enrolled in the Epidemiology of Diabetes Interventions and Complications study to a population based sample of women with normal glucose. MATERIALS AND METHODS: We performed a cross-sectional analysis of women with type 1 diabetes and normal glucose tolerance using 2 study populations. The Diabetes Control and Complications Trial cohort followup, Epidemiology of Diabetes Interventions and Complications, began in 1994. In 2004 women participants (550) completed a self-administered questionnaire on urinary incontinence. Our primary outcome was weekly or greater incontinence, overall and by type. Prevalence of urinary incontinence was compared to a subgroup of women with normal glucose in the 2001 to 2002 National Health and Nutrition Examination Survey (NHANES). RESULTS: Overall 65% of women with type 1 diabetes reported any urinary incontinence (17% reported weekly incontinence). Nearly 40% of these women were greatly bothered by their incontinence and 9% believed it affected their day-to-day activities. Women with type 1 diabetes had a nearly 2-fold greater prevalence of weekly urge incontinence compared to those without diabetes in the NHANES cohort (8.8% vs 4.5%, p = 0.01). CONCLUSIONS: Urinary incontinence is common in women with type 1 diabetes and the prevalence of weekly urge incontinence is far greater compared to that in women with normal glucose levels. Moreover, the prevalence of urinary incontinence in women with type 1 diabetes was greater than that of neuropathy, retinopathy and nephropathy. These findings highlight the importance of screening for urinary incontinence among women with type 1 diabetes. Studies examining factors associated with urinary incontinence in women with type 1 diabetes are warranted.
PURPOSE: We compared the prevalence, level of bother and effect on daily activities of urinary incontinence among women with type 1 diabetes enrolled in the Epidemiology of Diabetes Interventions and Complications study to a population based sample of women with normal glucose. MATERIALS AND METHODS: We performed a cross-sectional analysis of women with type 1 diabetes and normal glucose tolerance using 2 study populations. The Diabetes Control and Complications Trial cohort followup, Epidemiology of Diabetes Interventions and Complications, began in 1994. In 2004 womenparticipants (550) completed a self-administered questionnaire on urinary incontinence. Our primary outcome was weekly or greater incontinence, overall and by type. Prevalence of urinary incontinence was compared to a subgroup of women with normal glucose in the 2001 to 2002 National Health and Nutrition Examination Survey (NHANES). RESULTS: Overall 65% of women with type 1 diabetes reported any urinary incontinence (17% reported weekly incontinence). Nearly 40% of these women were greatly bothered by their incontinence and 9% believed it affected their day-to-day activities. Women with type 1 diabetes had a nearly 2-fold greater prevalence of weekly urge incontinence compared to those without diabetes in the NHANES cohort (8.8% vs 4.5%, p = 0.01). CONCLUSIONS:Urinary incontinence is common in women with type 1 diabetes and the prevalence of weekly urge incontinence is far greater compared to that in women with normal glucose levels. Moreover, the prevalence of urinary incontinence in women with type 1 diabetes was greater than that of neuropathy, retinopathy and nephropathy. These findings highlight the importance of screening for urinary incontinence among women with type 1 diabetes. Studies examining factors associated with urinary incontinence in women with type 1 diabetes are warranted.
Authors: James M Hotaling; Aruna V Sarma; Darshan P Patel; Barbara H Braffett; Patricia A Cleary; Eva Feldman; William H Herman; Catherine L Martin; Alan M Jacobson; Hunter Wessells; Rodica Pop-Busui Journal: Diabetes Care Date: 2016-06-28 Impact factor: 19.112
Authors: Hui Q Pan; Dan L Lin; Christopher Strauch; Robert S Butler; Vincent M Monnier; Firouz Daneshgari; Margot S Damaser Journal: Am J Physiol Renal Physiol Date: 2010-09-29
Authors: Shivani Bakre; Sarah K Holt; Mary Oerline; Barbara H Braffett; Rodica Pop-Busui; Hunter Wessells; Aruna V Sarma Journal: Neurourol Urodyn Date: 2021-10-21 Impact factor: 2.696
Authors: S M Lenherr; J Q Clemens; B H Braffett; R L Dunn; P A Cleary; C Kim; W H Herman; J M Hotaling; A M Jacobson; J S Brown; H Wessells; A V Sarma Journal: Diabet Med Date: 2016-04-24 Impact factor: 4.359
Authors: Rodica Pop-Busui; Barbara H Braffett; Hunter Wessells; William H Herman; Catherine L Martin; Alan M Jacobson; Aruna V Sarma Journal: Diabetes Care Date: 2022-01-01 Impact factor: 19.112